Avadel Pharmaceuticals

About:

Avadel is a biopharmaceutical company focused on transforming medicines to transform lives.

Website: https://www.avadel.com/

Twitter/X: AvadelPharma

Top Investors: RTW Investments, Frazier Healthcare Partners, Venrock Healthcare Capital Partners, Vivo Capital, Avoro Capital Advisors

Description:

Avadel Pharmaceuticals plc (Nasdaq:AVDL) is a specialty pharmaceutical company that seeks to develop differentiated pharmaceutical products that are safe, effective and easy to take through formulation development, by utilizing its proprietary drug delivery technology and through in-licensing / acquiring new products; ultimately, helping patients adhere to their prescribed medical treatment and see better results. Avadel’s current portfolio of products and product candidates focuses on the urology, central nervous system (CNS) / sleep, and hospital markets. The Company is headquartered in Dublin, Ireland with operations in St. Louis, Missouri and Lyon, France. For more information, please visit www.avadel.com.